Targeted radionuclide therapy for gastroenteropancreatic neuroendocrine tumors: From beta-emitters to next-generation alpha therapies

Best Practice & Research Clinical Gastroenterology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles